Abstract:Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. Its effect on access to HT of patients with rare causes of heart failure (HF) has not been assessed.METHODS:In this national study, including adults listed for HT between 2018 and 2020, we analyzed waitlist and posttransplant outcomes of candidates with rare causes of HF (restrictive cardiomyopathy [RCM], hypertrophic cardiomyopathy, and congenital heart disease). The primary end point was death on the waitlist or delisting for clinical deterioration. Secondary end points included access to HT and posttransplant mortality. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups. The association of HF cause with outcomes was determined by Fine-Gray or Cox models.RESULTS:Overall, 1604 candidates were listed for HT. At 1 year postlisting, 175 patients met the primary end point and 1040 underwent HT. Candidates listed for rare causes of HF significantly differed in baseline characteristics and had more frequent score exceptions compared with other cardiomyopathies (31.3%, 32.0%, 36.4%, and 16.7% for patients with hypertrophic cardiomyopathy, RCM, congenital heart disease, and other cardiomyopathies). The cumulative incidence of death on the waitlist and probability of HT were similar between diagnosis groups (P=0.17 and 0.40, respectively). The adjusted risk of death or delisting for clinical deterioration did not significantly differ between candidates with rare and common causes of HF (subdistribution hazard ratio (HR): hypertrophic cardiomyopathy, 0.51 [95% CI, 0.19–1.38];P=0.18; RCM, 1.04 [95% CI, 0.42–2.58];P=0.94; congenital heart disease, 1.82 [95% CI, 0.78–4.26];P=0.17). Similarly, the access to HT did not significantly differ between causes of HF (hypertrophic cardiomyopathy: HR, 1.18 [95% CI, 0.92–1.51];P=0.19; RCM: HR, 1.19 [95% CI, 0.90–1.58];P=0.23; congenital heart disease: HR, 0.76 [95% CI, 0.53–1.09];P=0.14). RCM was an independent risk factor for 1-year posttransplant mortality (HR, 2.12 [95% CI, 1.06–4.24];P=0.03).CONCLUSIONS:Our study shows equitable waitlist outcomes among HT candidates whatever the indication for transplantation with the new French allocation scheme.

New French heart allocation system: Comparison with Eurotransplant and US allocation systems

Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme

Survival outcomes following urgent lung transplantation in France and the USA

Allocation of liver grafts worldwide - Is there a best system?

"Take it or leave it": Analysis of pediatric heart offers for transplantation in Switzerland

Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk

Revised Heart Allocation Policy Improved Waitlist Mortality and Waiting Time With Maintained Outcomes in En-Bloc Heart-Lung Transplant Candidates and Recipients

Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality

A critical assessment on kidney allocation systems

Kidney Organ Allocation System: How to Be Fair

Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States

High-urgency Kidney Transplantation in the Eurotransplant Kidney Allocation System: Success or Waste of Organs? the Eurotransplant 15-Year All-Centre Survey

Pediatric heart allocation and transplantation in Eurotransplant

Contemporary Pediatric Heart Transplant Waitlist Mortality

Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis

Bridge to Transplantation: Policies Impact Practices

Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation

Potential Impact of the Proposed Revised UNOS Thoracic Organ Allocation System

Impact of the New Heart Allocation System on the Medium-Term Outcomes in Patients With Hypertrophic Cardiomyopathy

Organ distribution without geographic boundaries: A possible framework for organ allocation

Refining cPRA calculation to improve HLA compatibility assessment in organ transplantation: A detailed picture of the Paris waiting list